In colorectal cancers, the expression of Cyclin G2 is significantly upregulated in macrophages in response to IFN-γ, leading to increased secretion of CXCL9, enhanced CTL chemotaxis, and inhibition of angiogenesis. This evidence concerns the gene CXCL9 and colorectal cancer.